A small protein known as p11 may play a much broader role in cellular signaling than previously thought. Researchers at Karolinska institutet have now shown that p11 interacts with numerous receptors targeted by commonly used medicines, opening new possibilities for treating conditions such as pain, inflammation and depression. The research is published in the journal Science Advances.